Surgery Partners Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.4B+8.1% YoYTTM through 30 Jun 2026
Net Income -$88.6MTTM through 30 Jun 2026
Free Cash Flow $187.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 23.1% |
| EBITDA Margin | 16.7% |
| Operating Margin | 11.8% |
| Net Margin | -2.6% |
Returns
3.2%ROE
1.2%ROA
-1.7%ROIC
Balance Sheet Health
Debt / Equity1.18x
Current Ratio1.87x
Net Debt$3.5B
Cash & Equivalents$216.7M
Quality Metrics
Altman Z-Score0.70
Piotroski F-Score5 / 9
FCF Margin5.6%
Rule of 407.2
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $3.3B
Diluted EPS-$0.69TTMFY2025: $-0.61
Dividend
No dividend
Capital Allocation
Capex Intensity2.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Surgical Facilities | $3.2B | View detailsFocusing on higher-acuity procedures, organic growth, and portfolio optimization to selectively divest non-core surgical hospitals. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.